Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Philip Keye"'
Autor:
Philip Keye, Susanne Issleib, Yvonne Gier, Mateusz Glegola, Philip Maier, Daniel Böhringer, Philipp Eberwein, Thomas Reinhard
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Graft-versus-Host disease is a major complication of allogeneic stem cell transplantation. The eyes are a frequently affected organ with a severe dry eye disease being the hallmark manifestation. This retrospective study evaluates the effect
Externí odkaz:
https://doaj.org/article/0457839282624fdab251721165bb1656
Publikováno v:
Biomedicines, Vol 12, Iss 10, p 2212 (2024)
Background/Objectives: Recent prospective studies have shown that selective laser tra-beculoplasty (SLT) is a safe and cost-effective alternative to pressure-reducing eye drop therapy as a first-line treatment for ocular hypertension or open-angle gl
Externí odkaz:
https://doaj.org/article/136417229b5c4176839dc683cbd882eb
Autor:
Silvia Waldeck, Michael Rassner, Philip Keye, Marie Follo, Dieter Herchenbach, Cornelia Endres, Anne Charlet, Geoffroy Andrieux, Ulrich Salzer, Melanie Boerries, Justus Duyster, Nikolas vonBubnoff
Publikováno v:
Molecular Oncology, Vol 14, Iss 4, Pp 779-794 (2020)
FLT3‐ITD tyrosine kinase inhibitors (TKI) show limited clinical activity in acute myeloid leukemia (AML) due to emerging resistance. TKI resistance is mediated by secondary FLT3‐ITD mutations only in a minority of cases. We hypothesize that the c
Externí odkaz:
https://doaj.org/article/bd63d97f309d4829be7c3c0875737bfc
Publikováno v:
Cornea. 42:744-746
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd8baaffbe7db66a0fd082416a1e06ea
https://doi.org/10.1097/ico.0000000000003237
https://doi.org/10.1097/ico.0000000000003237
Autor:
Philip Keye, Anne Charlet, Michael Reth, Kathrin Kläsener, Max Kappenstein, Cornelia Endres, Teresa Poggio, Nikolas von Bubnoff, Anna Lena Illert, Jana Sänger, Stefanie Kreutmair, Cornelius Miething, Christoph Rummelt, Justus Duyster, Sivahari P. Gorantla
Publikováno v:
Leukemia. 36:701-711
FLT3-ITD is the most predominant mutation in AML being expressed in about one-third of AML patients and is associated with a poor prognosis. Efforts to better understand FLT3-ITD downstream signaling to possibly improve therapy response are needed. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fb8aa8e0d51349749e9a105ed9eb4bc
https://doi.org/10.1038/s41375-021-01462-4
https://doi.org/10.1038/s41375-021-01462-4
Publikováno v:
Notaufnahme up2date. 3:121-124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1710e0689a653351001165df923523c2
https://doi.org/10.1055/a-1397-9052
https://doi.org/10.1055/a-1397-9052
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 6; Pages: 2247
(1) Background: Due to significant variation, sporadic IOP measurements often fail to correctly assess the IOP situation in glaucoma patients. Thus, diurnal-nocturnal IOP profiles can be used as a diagnostic tool. The purpose of this study is to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c14f0c3f5b0a2b12a48f8fc1ea62f41b
https://doi.org/10.3390/jcm12062247
https://doi.org/10.3390/jcm12062247
Purpose: To assess the additional value of 48-hour diurnal-nocturnal IOP profiles in comparison to only 24-hour diurnal-nocturnal IOP profiles in the management of glaucoma.Methods: All diurnal-nocturnal IOP profiles over 48 hours that were taken bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dbfee7577d9f7f6f098087116b1a18e
https://doi.org/10.21203/rs.3.rs-736651/v1
https://doi.org/10.21203/rs.3.rs-736651/v1
Publikováno v:
Der Ophthalmologe. 117:700-703
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3f2ab9116c23ddeaae633113511ea5c
https://doi.org/10.1007/s00347-020-01107-4
https://doi.org/10.1007/s00347-020-01107-4
Autor:
Melanie Boerries, Geoffroy Andrieux, Ulrich Salzer, Michael Rassner, Silvia Waldeck, Nikolas von Bubnoff, Anne Charlet, Dieter Herchenbach, Justus Duyster, Cornelia Endres, Philip Keye, Marie Follo
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 14, Iss 4, Pp 779-794 (2020)
Molecular Oncology, Vol 14, Iss 4, Pp 779-794 (2020)
FLT3‐ITD tyrosine kinase inhibitors (TKI) show limited clinical activity in acute myeloid leukemia (AML) due to emerging resistance. TKI resistance is mediated by secondary FLT3‐ITD mutations only in a minority of cases. We hypothesize that the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e34a480c7832b6726c4b8e70e3183f09
https://doi.org/10.1002/1878-0261.12640
https://doi.org/10.1002/1878-0261.12640